MYO9B and type 1 diabetes mellitus: Since the 33-bp deletion identified in ALR mice is not conserved between mouse and human, we therefore conducted targeted sequencing of MYO9B along with comparative biostatistical analysis in 260 T1D cases and 240 healthy controls (Fig. 9a).